5.41 USD
-0.35 (-6.08%)
Overall QLI gets a fundamental rating of 2 out of 10. We evaluated QLI against 190 industry peers in the Pharmaceuticals industry. While QLI seems to be doing ok healthwise, there are quite some concerns on its profitability. QLI is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- In the past year QLI has reported negative net income.
- In the past year QLI had a positive cash flow from operations.
- Of the past 5 years QLI 4 years were profitable.
- QLI had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- QLI's Return On Assets of -15.18% is fine compared to the rest of the industry. QLI outperforms 66.84% of its industry peers.
- QLI's Return On Equity of -18.18% is fine compared to the rest of the industry. QLI outperforms 74.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.18% | ||
| ROE | -18.18% | ||
| ROIC | N/A |
ROA(3y)-3.11%
ROA(5y)3.26%
ROE(3y)-3.47%
ROE(5y)7.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- QLI's Gross Margin of 3.77% is in line compared to the rest of the industry. QLI outperforms 48.70% of its industry peers.
- In the last couple of years the Gross Margin of QLI has declined.
- QLI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 3.77% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-37%
GM growth 5Y-25.24%
2. Health
2.1 Basic Checks
- QLI does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, QLI has less shares outstanding
- Compared to 1 year ago, QLI has an improved debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 4.38 indicates that QLI is not in any danger for bankruptcy at the moment.
- QLI has a Altman-Z score of 4.38. This is in the better half of the industry: QLI outperforms 78.76% of its industry peers.
- QLI has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
- QLI's Debt to Equity ratio of 0.01 is in line compared to the rest of the industry. QLI outperforms 57.51% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.38 |
ROIC/WACCN/A
WACC8.08%
2.3 Liquidity
- A Current Ratio of 5.18 indicates that QLI has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 5.18, QLI is in the better half of the industry, outperforming 61.66% of the companies in the same industry.
- A Quick Ratio of 4.43 indicates that QLI has no problem at all paying its short term obligations.
- QLI has a Quick ratio (4.43) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.18 | ||
| Quick Ratio | 4.43 |
3. Growth
3.1 Past
- QLI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -3727.33%.
- Looking at the last year, QLI shows a very negative growth in Revenue. The Revenue has decreased by -28.35% in the last year.
- Measured over the past years, QLI shows a decrease in Revenue. The Revenue has been decreasing by -1.60% on average per year.
EPS 1Y (TTM)-3727.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3958.33%
Revenue 1Y (TTM)-28.35%
Revenue growth 3Y-2.43%
Revenue growth 5Y-1.6%
Sales Q2Q%-47.18%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- QLI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- QLI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
QILIAN INTERNATIONAL HOLDING / QLI FAQ
What is the ChartMill fundamental rating of QILIAN INTERNATIONAL HOLDING (QLI) stock?
ChartMill assigns a fundamental rating of 3 / 10 to QLI.
Can you provide the valuation status for QILIAN INTERNATIONAL HOLDING?
ChartMill assigns a valuation rating of 0 / 10 to QILIAN INTERNATIONAL HOLDING (QLI). This can be considered as Overvalued.
Can you provide the profitability details for QILIAN INTERNATIONAL HOLDING?
QILIAN INTERNATIONAL HOLDING (QLI) has a profitability rating of 3 / 10.
What is the financial health of QILIAN INTERNATIONAL HOLDING (QLI) stock?
The financial health rating of QILIAN INTERNATIONAL HOLDING (QLI) is 6 / 10.